FDA — authorised 18 August 2003
- Application: ANDA076453
- Marketing authorisation holder: FOUGERA PHARMS
- Local brand name: LIDOCAINE AND PRILOCAINE
- Indication: CREAM — TOPICAL
- Status: approved
FDA authorised lidocaine and prilocaine on 18 August 2003
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 18 August 2003; FDA authorised it on 27 August 2003; FDA authorised it on 25 September 2003.
FOUGERA PHARMS holds the US marketing authorisation.